A method of drying an anesthesia breathing system includes removing a CO.sub.2 absorber from the anesthesia breathing system, when the CO.sub.2 absorber is connected to an absorber inlet port and an absorber outlet port. The method further includes moving a bag-to-vent flow diverter to an intermediate position so as to simultaneously open both a bag channel and a ventilator channel, and connecting an inspiratory port and an expiratory port of the anesthesia breathing system together. A dry gas source is connected to an absorber outlet channel, and then a dry gas flow is provided through the bag channel and the ventilator channel so as to dry out moisture from a bag circuit and a ventilator circuit of the anesthesia breathing system.

A gas washout vent, and a patient interface with the gas washout vent, configured to allow patient-exhaled CO.sub.2 to flow to an exterior of the plenum chamber to minimise rebreathing of exhaled CO.sub.2 by the patient, the gas washout vent including at least one outlet orifice; a diffusing member at least partly covering the outlet orifice; and a blocking member having an air-impermeable material, the blocking member preventing gas exiting from the outlet orifice from flowing straight through the diffusing member.

A gas washout vent, and a patient interface with the gas washout vent, configured to allow patient-exhaled CO.sub.2 to flow to an exterior of the plenum chamber to minimise rebreathing of exhaled CO.sub.2 by the patient, the gas washout vent including at least one outlet orifice; a diffusing member at least partly covering the outlet orifice; and a blocking member having an air-impermeable material, the blocking member preventing gas exiting from the outlet orifice from flowing straight through the diffusing member.

The invention relates to a flow indicator preferably to be used in oxygen therapy treatment of patients where a clear flow or no flow state must be signaled for the supply of oxygen.

According to the inventive flow indicator are two cylindrical bodies used, one (30) movable and one (10) stationary, and with one extended flow restriction passage (80) that forces the movable cylindrical body away from a sight glass (40), instead exposing the stationary cylindrical body. The viewable cylindrical part of the movable part may be colored red (R), and the viewable cylindrical part of the stationary body may be colored green (G).

A flow indicator with quick and stable indication of developed flow is obtained.

In general, this disclosure describes techniques for removing trace and low concentration CO.sub.2 from fluids using SIFSIX-n-M MOFs, wherein n is at least two and M is a metal. In some embodiments, the metal is zinc or copper. Embodiments include devices comprising SIFSIX-n-M MOFs for removing CO.sub.2 from fluids. In particular, embodiments relate to devices and methods utilizing SIFSIX-n-M MOFs for removing CO.sub.2 from fluids, wherein CO.sub.2 concentration is trace. Methods utilizing SIFSIX-n-M MOFs for removing CO.sub.2 from fluids can occur in confined spaces. SIFSIX-n-M MOFs can comprise bidentate organic ligands. In a specific embodiment, SIFSIX-n-M MOFs comprise pyrazine or dipryidilacetylene ligands.

In general, this disclosure describes techniques for removing trace and low concentration CO.sub.2 from fluids using SIFSIX-n-M MOFs, wherein n is at least two and M is a metal. In some embodiments, the metal is zinc or copper. Embodiments include devices comprising SIFSIX-n-M MOFs for removing CO.sub.2 from fluids. In particular, embodiments relate to devices and methods utilizing SIFSIX-n-M MOFs for removing CO.sub.2 from fluids, wherein CO.sub.2 concentration is trace. Methods utilizing SIFSIX-n-M MOFs for removing CO.sub.2 from fluids can occur in confined spaces. SIFSIX-n-M MOFs can comprise bidentate organic ligands. In a specific embodiment, SIFSIX-n-M MOFs comprise pyrazine or dipryidilacetylene ligands.

The present invention relates generally to the fields of treating psychiatric disorders, in particular, anxiety disorders including post-traumatic stress disorder (PTSD) in subjects, e.g., human subjects, by administering a xenon and/or argon containing composition. Treatments can also employ psychotherapy in combination with administration of xenon and/or argon, alone or in combination with additional psychotherapeutic medications to treat the anxiety disorder and reduce a symptom of the anxiety disorder in the subject.

A system and method for determining a remaining processing capacity of a scrubber having a flow path and a processing material disposed along the flow path. A device may comprise a plurality of optical sensors disposed within the processing material and arranged along the flow path, a light source, and a processor for determining the capacity according to signals received from the optical sensor. The device may be used to illuminate processing material adjacent to each optical sensor using the light source, measure a light value reflected by the processing material at each optical sensor, and determine the remaining processing capacity of the scrubber, using the processor, based on the measured light value. Devices may comprise a memory, such as a non-volatile memory to allow multiple uses of a scrubber without reloading with fresh processing material.

The present invention relates to a method and apparatus for facilitating anaesthesia, particularly in Re-Breather anaesthetic circuits. A problem with Re-Breather circuits is that their dynamic response can be relatively slow. The dynamic response is the response of the circuit to delivering changes of anaesthetic concentration. In current circuits, Fresh Gas containing anaesthetic is delivered into the circuit and may be substantially diluted by the gas already present in the circuit. It is therefore difficult to achieve a rapid increase of anaesthetic concentration for delivery to the patient. In the present invention, an accumulator is placed in the Re-Breather circuit to accumulate Fresh Gas containing anaesthetic as it is introduced into the circuit, adjacent an inhalation conduit to the patient. Fresh Gas containing high concentrations of anaesthetic is therefore immediately available to the patient.

The present invention relates to a method and apparatus for facilitating anaesthesia, particularly in Re-Breather anaesthetic circuits. A problem with Re-Breather circuits is that their dynamic response can be relatively slow. The dynamic response is the response of the circuit to delivering changes of anaesthetic concentration. In current circuits, Fresh Gas containing anaesthetic is delivered into the circuit and may be substantially diluted by the gas already present in the circuit. It is therefore difficult to achieve a rapid increase of anaesthetic concentration for delivery to the patient. In the present invention, an accumulator is placed in the Re-Breather circuit to accumulate Fresh Gas containing anaesthetic as it is introduced into the circuit, adjacent an inhalation conduit to the patient. Fresh Gas containing high concentrations of anaesthetic is therefore immediately available to the patient.